Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Aldosterone and Potassium in Heart Failure
Author(s): Laibah Arshad Khan , Adeena Jamil , Stephen J Greene , et al Added: 1 year ago

Heart Failure

Prevention & Chronic Conditions
FDA Approves Finerenone for Heart Failure with LVEF ≥40%
Added: 5 months ago Source:  Radcliffe Cardiology
The US Food and Drug Administration (FDA) has approved the non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) finerenone (Kerendia, Bayer). The new indication is for adult patients with heart failure (HF) and a left ventricular ejection fraction (LVEF) of ≥40% to reduce the risk of cardiovascular death, hospitalisation for heart failure, and urgent heart failure visits.¹ The… View more

Cardiovascular Renal Metabolic

Guidelines & Statements
The Aldosterone Story: New Chapters
Author(s): Vijay Chopra Added: 6 months ago

Heart Failure
Benefits of Spironolactone: Win Ratio Analysis of the TOPCAT Trial
Author(s): Dung Viet Nguyen , Hoai Thi Thu Nguyen Added: 3 months ago

Heart Failure
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s): Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan Added: 1 year ago

Heart Failure

MI/ACS
Guideline-directed Medical Therapy is the Most Effective Decongestion
Author(s): Jelena Celutkiene , Alexandre Mebazaa , Jan Biegus , et al Added: 11 months ago

Heart Failure
Finerenone: Will It Be a Game-changer?
Author(s): Dinesh Khullar , Anish Kumar Gupta , Kulwant Singh Added: 1 year ago

Cardiovascular Renal Metabolic

Heart Failure
Pharmacological Therapy of HFrEF in 2025
Author(s): Massimo Mapelli , Filippo Maria Rubbo , Simona Costantino , et al Added: 6 months ago

Heart Failure